[1] |
WANG Zezhou , ZHANG Yang , MO Miao , YUAN Jing , ZHOU Changming , SHEN Jie , FENG Xiaoshuang , WU Haoxuan , LI Hang , YE Ting , HU Hong , CHEN Haiquan , ZHENG Ying .
Distribution of metastatic sites and survival analysis of patients with non-metastatic lung cancer at initial diagnosis based on hospital registration
[J]. China Oncology, 2021, 31(9): 775-782.
|
[2] |
HU Xi’e , YANG Zhenyu , XUE Jingyi , YANG Ping , PENG Shujia , YUAN Lijuan , BAO Guoqiang .
Research progress of single-cell sequencing in neoadjuvant chemotherapy for triple-negative breast cancer
[J]. China Oncology, 2021, 31(3): 221-226.
|
[3] |
JIANG Mengyi , LU Yanqiao , WANG Hongxia .
Research progress and clinical significance of breast cancer heterogeneity
[J]. China Oncology, 2020, 30(5): 394-400.
|
[4] |
SHI Zhiqiang , QIU Pengfei , LIU Yanbing , ZHAO Tong , SUN Xiao , CHEN Peng , WANG Chunjian , ZHANG Zhaopeng , CONG Binbin , WANG Yongsheng .
Selective elimination of axillary surgery staging after neoadjuvant chemotherapy for HER2 positive and triple-negative breast cancer
[J]. China Oncology, 2020, 30(3): 186-191.
|
[5] |
LIU Yongzhi, ZHAO Yonghua, JIANG Hai, BAO Liping, WU Wei, SUN Qiang, JIANG Huichuan, JIA Zhaobo, HAO Shichao.
Clinicopathological characteristics and survival analysis of patients with mucinous breast carcinoma based on SEER database
[J]. China Oncology, 2019, 29(12): 955-960.
|
[6] |
CAO Xiaoshan, CONG Binbin.
The progress of treatment for triple-negative breast cancer in the era of precision medicine
[J]. China Oncology, 2019, 29(12): 971-976.
|
[7] |
ZHENG Xiaying, CHEN Junxia.
Expression of circRNA hsa_circ_0005320 in triple-negative breast cancer and its effect on cell proliferation
[J]. China Oncology, 2019, 29(11): 845-854.
|
[8] |
ZHU Xiuzhi, CHEN Li, JI Lei, GAO Yu, WANG Zhonghua.
Advances in the treatment of triple-negative breast cancer with CDK4/6 inhibitors
[J]. China Oncology, 2019, 29(11): 899-905.
|
[9] |
YANG Rui, CHEN Junxia.
Effects of circular RNA hsa_circ_0058514 on the development and progression of triple-negative breast cancer
[J]. China Oncology, 2019, 29(1): 9-18.
|
[10] |
LI Jiawei, SHI Zhaoting, HOU Yingmin, et al.
Clinicopathological and immunohistochemical basis for sonographic characteristics of triple-negative invasive breast cancer
[J]. China Oncology, 2019, 29(1): 37-44.
|
[11] |
JI Peng, GONG Yue, DI Genhong.
Latest research progress on tumor-infiltrating lymphocytes in HER2-positive and triple-negative breast cancer
[J]. China Oncology, 2018, 28(12): 928-934.
|
[12] |
LING Hong, XU Xiaoli.
The survival analysis of patients with Paget’s disease and underlying invasive breast carcinoma
[J]. China Oncology, 2017, 27(8): 655-660.
|
[13] |
LIU Zimei, YU Wenxi, SUN Chu, et al.
Clinical significance of ICAM-1 expression and its correlation with prognosis of triple-negative breast cancer
[J]. China Oncology, 2017, 27(2): 121-127.
|
[14] |
ZHANG Tingting, QU Ning, SHI Rongliang, et al.
Effects of BRAF V600E mutation on oncogenesis and prognosis in papillary thyroid cancer
[J]. China Oncology, 2017, 27(2): 145-150.
|
[15] |
LIU Zimei, SHEN Zan.
The latest developments in targeted therapy for triple-negative breast cancer
[J]. China Oncology, 2017, 27(1): 36-40.
|